Det var ju inlägget om att Norge öppnat du svarat på och började skriva om skillnad mellan Norge och Sverige...
Bara kolla dina egna inlägg några sidor bakåt.
Fler i Sverige erbjuds nu en tredje dos.
1/9 började det från FHM, men nu blir det alltså fler som ingår i dos 3.
www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2021/september/pafyllnadsdos-vaccin-mot-covid-19-till-alla-som-ar-80-ar-och-aldre/
Folkhälsomyndigheten rekommenderar att personer med ökad risk för svår covid-19 erbjuds en påfyllnadsdos vaccin mot sjukdomen. Beslutet omfattar personer i särskilt boende för äldre (SÄBO), personer med hemsjukvård och hemtjänst samt alla som är 80 år och äldre.
Därför har Folkhälsomyndigheten beslutat att rekommendera en tredje dos vaccin som påfyllnad för personer i följande grupper, och i denna prioriteringsordning:
Rekommendationen är att erbjuda en dos av ett mRNA-vaccin, om det gått minst sex månader sedan förra vaccinationstillfället.
FHM beslutsunderlag till att 12-15 åringar erbjuds vaccin:
Både grafen och de två tabellerna var också intressanta .
Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
www.cdc.gov/mmwr/volumes/70/wr/mm7039e4.htm
On September 22, 2021, FDA authorized an additional dose of Pfizer-BioNTech vaccine ≥6 months after completion of the primary series among persons aged ≥65 years, at high risk for severe COVID-19, or whose occupational or institutional exposure puts them at high risk for COVID-19
...
An additional dose of mRNA COVID-19 vaccine is recommended for persons with moderately to severely immunocompromising conditions (5). CDC recommended an additional dose of Pfizer-BioNTech vaccine ≥6 months after completion of the primary vaccine series among persons aged ≥65 years, residents in long-term care settings, and persons aged 50–64 years with underlying medical conditions; persons aged 18-49 years with underlying medical conditions and persons aged 18–64 years at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive an additional dose based on their individual benefits and risks (8). Initial analyses of safety data from >22,000 v-safe registrants shows that local reactions are slightly increased and systemic reactions are slightly decreased after dose 3 of an mRNA than after dose 2. No unexpected patterns of adverse reactions were identified; those reported were mild to moderate and transient. CDC will continue to monitor the safety of additional doses of COVID-19 vaccine. Additional data on adverse reactions associated with different combinations of vaccines and of time since completion of primary series will be important to guide public health recommendations.
Table 2, tyvärr med avbrott i mitten men upprepad rad så allt finns med. 
Annars finns den ju på länken.
Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
